390 related articles for article (PubMed ID: 36754245)
1. CB2R activation ameliorates late adolescent chronic alcohol exposure-induced anxiety-like behaviors during withdrawal by preventing morphological changes and suppressing NLRP3 inflammasome activation in prefrontal cortex microglia in mice.
Li J; Wang H; Liu D; Li X; He L; Pan J; Shen Q; Peng Y
Brain Behav Immun; 2023 May; 110():60-79. PubMed ID: 36754245
[TBL] [Abstract][Full Text] [Related]
2. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.
Shao BZ; Wei W; Ke P; Xu ZQ; Zhou JX; Liu C
CNS Neurosci Ther; 2014 Dec; 20(12):1021-8. PubMed ID: 25417929
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
4. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
Front Immunol; 2019; 10():1511. PubMed ID: 31327964
[TBL] [Abstract][Full Text] [Related]
5. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages.
Ke P; Shao BZ; Xu ZQ; Wei W; Han BZ; Chen XW; Su DF; Liu C
PLoS One; 2016; 11(9):e0155076. PubMed ID: 27611972
[TBL] [Abstract][Full Text] [Related]
6. Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior.
Zhang M; Wang XL; Shi H; Meng LQ; Quan HF; Yan L; Yang HF; Peng XD
J Immunol Res; 2022; 2022():9313436. PubMed ID: 36339940
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice.
Tastan B; Arioz BI; Tufekci KU; Tarakcioglu E; Gonul CP; Genc K; Genc S
Front Immunol; 2021; 12():737065. PubMed ID: 34858398
[TBL] [Abstract][Full Text] [Related]
8. The NRF2 activator RTA-408 ameliorates chronic alcohol exposure-induced cognitive impairment and NLRP3 inflammasome activation by modulating impaired mitophagy initiation.
Lin X; Wang H; Zou L; Yang B; Chen W; Rong X; Zhang X; He L; Li X; Peng Y
Free Radic Biol Med; 2024 Aug; 220():15-27. PubMed ID: 38679301
[TBL] [Abstract][Full Text] [Related]
9. Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats.
Pan Y; Chen XY; Zhang QY; Kong LD
Brain Behav Immun; 2014 Oct; 41():90-100. PubMed ID: 24859041
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ.
Rodrigues FDS; Newton WR; Tassinari ID; da Cunha Xavier FH; Marx A; de Fraga LS; Wright K; Guedes RP; Bambini-Jr V
Neurochem Int; 2024 Jul; 177():105769. PubMed ID: 38761855
[TBL] [Abstract][Full Text] [Related]
11. Activation of cannabinoid-2 receptor protects against Pseudomonas aeruginosa induced acute lung injury and inflammation.
Nagre N; Nicholson G; Cong X; Lockett J; Pearson AC; Chan V; Kim WK; Vinod KY; Catravas JD
Respir Res; 2022 Dec; 23(1):326. PubMed ID: 36463179
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine.
Gong W; Zhang S; Zong Y; Halim M; Ren Z; Wang Y; Ma Y; Li B; Ma L; Zhou G; Yu J; Zhang J; Liu Q
J Affect Disord; 2019 Jul; 254():15-25. PubMed ID: 31082627
[TBL] [Abstract][Full Text] [Related]
13. Exacerbating effects of single-dose acute ethanol exposure on neuroinflammation and amelioration by GPR110 (ADGRF1) activation.
Banerjee S; Park T; Kim YS; Kim HY
J Neuroinflammation; 2023 Aug; 20(1):187. PubMed ID: 37580715
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury.
Jiang F; Xia M; Zhang Y; Chang J; Cao J; Zhang Z; Qian Z; Yang L
Front Immunol; 2022; 13():993168. PubMed ID: 36238284
[TBL] [Abstract][Full Text] [Related]
15. miR-99b-3p/Mmp13 axis regulates NLRP3 inflammasome-dependent microglial pyroptosis and alleviates neuropathic pain via the promotion of autophagy.
Gao X; Gao LF; Zhang ZY; Jia S; Meng CY
Int Immunopharmacol; 2024 Jan; 126():111331. PubMed ID: 38061116
[TBL] [Abstract][Full Text] [Related]
16. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
Liu Y; Dai Y; Li Q; Chen C; Chen H; Song Y; Hua F; Zhang Z
Neurosci Lett; 2020 Sep; 736():135279. PubMed ID: 32726591
[TBL] [Abstract][Full Text] [Related]
17. JLX001 ameliorates cerebral ischemia injury by modulating microglial polarization and compromising NLRP3 inflammasome activation via the NF-κB signaling pathway.
Bian HJ; Xu SY; Li HQ; Jia JQ; Ye L; Shu S; Xia SN; Gu Y; Zhu X; Xu Y; Cao X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108325. PubMed ID: 34740080
[TBL] [Abstract][Full Text] [Related]
18. Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-κB pathway in a chronic migraine model.
Sun S; Fan Z; Liu X; Wang L; Ge Z
J Headache Pain; 2024 Jan; 25(1):3. PubMed ID: 38177990
[TBL] [Abstract][Full Text] [Related]
19. Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy.
Moraes CA; Hottz ED; Dos Santos Ornellas D; Adesse D; de Azevedo CT; d'Avila JC; Zaverucha-do-Valle C; Maron-Gutierrez T; Barbosa HS; Bozza PT; Bozza FA
Mol Neurobiol; 2023 Feb; 60(2):481-494. PubMed ID: 36280654
[TBL] [Abstract][Full Text] [Related]
20. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
